BMY

Bristol-Myers Squibb Company NYSE

Healthcare ·Drug Manufacturers - General ·US · bms.com

$58.22

Mkt Cap $118.8B

52w Low $42.52 77.1% of range 52w High $62.89

50d MA $59.55 200d MA $51.88

P/E (TTM) 16.8x

EV/EBITDA 10.1x

P/B 6.4x

Debt/Equity 2.5x

ROE 38.2%

P/FCF 8.6x

RSI (14) —

ATR (14) —

Beta 0.27

50d MA $59.55

200d MA $51.88

Avg Volume 12.3M

About

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in ri…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	BMO	1.42	1.58	+11.3%	57.59	+0.2%	+5.2%	+1.1%	—	—	—	—	—
Feb 5, 2026	BMO	1.23	1.26	+2.4%	57.62	+2.2%	+3.3%	+7.6%	+5.5%	+5.6%	+4.0%	+5.2%	—
Oct 30, 2025	BMO	1.52	1.63	+7.2%	42.60	+1.6%	+7.1%	+8.1%	+8.0%	+7.0%	+9.1%	+15.4%	—
Jul 31, 2025	BMO	1.09	1.46	+33.9%	45.98	-3.9%	-5.8%	-3.8%	-1.3%	-0.3%	-2.5%	+3.1%	—
Apr 24, 2025	BMO	1.49	1.80	+20.8%	48.52	-1.2%	+0.4%	-1.3%	-0.1%	+1.4%	+3.5%	-3.4%	—
Feb 6, 2025	BMO	1.47	1.67	+13.6%	59.71	-3.9%	-3.8%	-4.8%	-7.0%	-6.3%	-6.0%	+5.7%	—
Oct 31, 2024	BMO	1.49	1.80	+20.8%	52.66	+2.2%	+5.9%	+3.2%	+5.3%	+6.2%	+5.0%	+13.8%	—
Jul 26, 2024	BMO	1.62	2.07	+27.8%	45.27	+6.6%	+11.4%	+8.2%	+8.3%	+5.1%	+6.4%	+6.6%	—
Apr 25, 2024	BMO	-4.41	-4.40	+0.2%	48.86	-3.0%	-8.5%	-8.2%	-8.6%	-10.1%	-9.5%	-17.1%	—
Feb 2, 2024	BMO	1.52	1.70	+11.8%	48.67	+1.2%	+0.1%	-1.4%	+1.2%	-0.1%	+0.1%	+4.6%	—
Oct 26, 2023	BMO	1.76	2.00	+13.6%	56.61	-4.7%	-6.4%	-9.9%	-9.5%	-9.0%	-9.4%	-13.4%	—
Jul 27, 2023	BMO	1.99	1.75	-12.1%	63.41	-3.8%	-4.2%	-3.2%	-1.9%	-3.0%	-2.6%	-2.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 9	BofA Securities	Maintains	Buy → Buy	—	$59.20	$58.70	-0.8%	+0.5%	-1.0%	-1.9%	-1.9%	-2.2%
Apr 8	Guggenheim	Maintains	Buy → Buy	—	$57.67	$58.01	+0.6%	+2.7%	+3.1%	+1.6%	+0.7%	+0.7%
Apr 8	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$57.67	$58.01	+0.6%	+2.7%	+3.1%	+1.6%	+0.7%	+0.7%
Mar 17	HSBC	Maintains	Hold → Hold	—	$59.71	$60.13	+0.7%	+0.0%	-0.6%	-2.7%	-3.7%	-4.5%
Feb 23	Piper Sandler	Maintains	Overweight → Overweight	—	$60.66	$60.97	+0.5%	+1.0%	+1.5%	+1.1%	+0.7%	+2.8%
Feb 6	Citigroup	Maintains	Neutral → Neutral	—	$59.52	$60.00	+0.8%	+4.1%	+2.1%	+2.3%	+0.7%	+0.6%
Feb 6	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$59.52	$60.00	+0.8%	+4.1%	+2.1%	+2.3%	+0.7%	+0.6%
Feb 6	Guggenheim	Maintains	Buy → Buy	—	$59.52	$60.00	+0.8%	+4.1%	+2.1%	+2.3%	+0.7%	+0.6%
Jan 28	Piper Sandler	Maintains	Overweight → Overweight	—	$55.56	$55.01	-1.0%	-1.7%	-2.3%	-0.9%	+0.6%	+0.8%
Jan 27	Citigroup	Maintains	Neutral → Neutral	—	$54.60	$54.56	-0.1%	+1.8%	+0.0%	-0.6%	+0.8%	+2.4%
Jan 13	Leerink Partners	Maintains	Outperform → Outperform	—	$55.77	$55.94	+0.3%	+0.3%	+2.2%	+1.5%	-0.9%	-2.8%
Jan 9	Scotiabank	Maintains	Sector Perform → Sector Perform	—	$55.90	$55.72	-0.3%	-0.1%	-0.2%	+0.0%	+2.0%	+1.3%
Jan 7	Citigroup	Maintains	Neutral → Neutral	—	$54.42	$55.24	+1.5%	+4.2%	+2.7%	+2.6%	+2.5%	+2.8%
Jan 7	UBS	Upgrade	Neutral → Buy	—	$54.42	$55.24	+1.5%	+4.2%	+2.7%	+2.6%	+2.5%	+2.8%
Dec 15	BofA Securities	Upgrade	Neutral → Buy	—	$52.41	$53.50	+2.1%	+3.6%	+3.5%	+2.2%	+1.8%	+3.4%
Dec 12	Guggenheim	Upgrade	Neutral → Buy	—	$51.20	$52.27	+2.1%	+2.4%	+6.0%	+5.9%	+4.6%	+4.2%
Dec 12	Morgan Stanley	Maintains	Underweight → Underweight	—	$51.20	$52.27	+2.1%	+2.4%	+6.0%	+5.9%	+4.6%	+4.2%
Dec 10	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$50.65	$50.79	+0.3%	+1.1%	+1.1%	+3.5%	+7.2%	+7.1%
Dec 4	Scotiabank	Maintains	Sector Perform → Sector Perform	—	$50.96	$50.80	-0.3%	+1.9%	+2.3%	+1.4%	-0.6%	+0.5%
Dec 2	Goldman Sachs	Maintains	Neutral → Neutral	—	$49.18	$48.95	-0.5%	-1.9%	+3.6%	+5.6%	+6.0%	+5.1%
Nov 17	Citigroup	Maintains	Neutral → Neutral	—	$46.65	$46.52	-0.3%	+0.3%	+0.9%	-1.8%	-1.5%	-0.9%
Aug 1	Citigroup	Maintains	Neutral → Neutral	—	$43.31	$43.61	+0.7%	+2.1%	+4.8%	+5.9%	+3.5%	+4.7%
Jul 10	Morgan Stanley	Maintains	Underweight → Underweight	—	$47.66	$47.45	-0.4%	+1.8%	-1.7%	-0.7%	-2.6%	-1.0%
Apr 28	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$47.90	$48.31	+0.9%	+1.2%	+2.8%	+4.8%	+3.6%	+5.6%
Apr 23	Jefferies	Maintains	Buy → Buy	—	$49.82	$47.63	-4.4%	-2.6%	-2.3%	-3.9%	-2.7%	-1.2%
Apr 23	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$49.82	$47.63	-4.4%	-2.6%	-2.3%	-3.9%	-2.7%	-1.2%
Apr 11	UBS	Maintains	Neutral → Neutral	—	$50.46	$50.47	+0.0%	+0.5%	+1.7%	-0.9%	-2.2%	-2.4%
Apr 8	Goldman Sachs	Downgrade	Buy → Neutral	—	$55.19	$55.17	-0.0%	-3.8%	-2.6%	-8.6%	-8.1%	-7.0%
Feb 7	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$57.42	$57.46	+0.1%	-1.0%	-3.3%	-2.6%	-2.2%	-2.5%
Feb 4	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$59.95	$58.87	-1.8%	-1.4%	-0.4%	-4.2%	-5.2%	-7.4%
Jan 28	Citigroup	Maintains	Neutral → Neutral	—	$60.62	$60.28	-0.6%	-3.1%	-2.6%	-2.4%	-2.8%	-1.1%
Jan 8	Truist	Maintains	Buy → Buy	—	$57.14	$56.98	-0.3%	-0.6%	-2.3%	-3.1%	-2.5%	-2.2%
Dec 16	Jefferies	Upgrade	Hold → Buy	—	$55.78	$56.77	+1.8%	+0.2%	+3.4%	+1.9%	+0.9%	+2.8%
Nov 12	BMO Capital	Maintains	Market Perform → Market Perform	—	$59.82	$59.82	+0.0%	-1.3%	-2.4%	-2.2%	-6.0%	-5.0%
Nov 12	Leerink Partners	Upgrade	Market Perform → Outperform	—	$59.82	$59.82	+0.0%	-1.3%	-2.4%	-2.2%	-6.0%	-5.0%
Nov 12	Morgan Stanley	Maintains	Underweight → Underweight	—	$59.82	$59.82	+0.0%	-1.3%	-2.4%	-2.2%	-6.0%	-5.0%
Nov 12	Citigroup	Maintains	Neutral → Neutral	—	$59.82	$59.82	+0.0%	-1.3%	-2.4%	-2.2%	-6.0%	-5.0%
Nov 1	BMO Capital	Maintains	Market Perform → Market Perform	—	$55.77	$55.88	+0.2%	-2.6%	-0.6%	+0.3%	-0.9%	-1.9%
Oct 25	Citigroup	Downgrade	Buy → Neutral	—	$52.92	$52.68	-0.5%	-1.9%	-0.5%	-0.8%	-0.5%	+5.4%
Oct 18	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$53.18	$53.26	+0.2%	+0.1%	-2.0%	-0.8%	-0.2%	-0.5%
Oct 9	UBS	Maintains	Neutral → Neutral	—	$52.48	$52.25	-0.4%	+0.6%	-0.2%	-0.5%	+0.4%	+0.5%
Oct 7	TD Cowen	Maintains	Hold → Hold	—	$53.96	$54.00	+0.1%	-1.0%	-2.7%	-2.1%	-2.9%	-3.3%
Oct 7	Barclays	Maintains	Underweight → Underweight	—	$53.96	$54.00	+0.1%	-1.0%	-2.7%	-2.1%	-2.9%	-3.3%
Sep 27	BMO Capital	Maintains	Market Perform → Market Perform	—	$50.12	$51.54	+2.8%	+1.6%	+3.2%	+5.5%	+7.3%	+8.1%
Sep 23	BMO Capital	Maintains	Market Perform → Market Perform	—	$49.41	$49.56	+0.3%	+1.2%	+3.1%	+1.1%	+1.4%	+3.0%
Sep 16	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$49.13	$49.50	+0.8%	+1.8%	+0.7%	+1.2%	-0.2%	+0.6%
Aug 28	Jefferies	Maintains	Hold → Hold	—	$48.12	$48.12	+0.0%	+2.0%	+3.3%	+3.8%	+5.0%	+3.8%
Aug 22	Barclays	Maintains	Underweight → Underweight	—	$48.44	$48.57	+0.3%	-1.7%	-0.7%	-0.4%	-0.7%	+1.3%
Aug 12	TD Cowen	Maintains	Hold → Hold	—	$46.72	$46.77	+0.1%	+0.7%	+5.0%	+3.6%	+5.1%	+5.7%
Jul 29	Barclays	Downgrade	Equal Weight → Underweight	—	$50.45	$49.92	-1.1%	-2.9%	-2.8%	-5.7%	-4.5%	-3.3%